目的：利用软骨微粒脱细胞基质这种新型支架材料及纤维蛋白胶，体外构建可塑形及具有良好生物相容性的组织工程化软骨。
AIM: To establish engineered cartilage with good biocompatibility and plasticity in vitro with fibrin glue and a new material of stent made by cartilage microparticle acellular tissue matrix (CMACTM).
目的为体外构建组织工程瓣提供脱细胞的同种生物瓣支架材料，并建立相应的技术方法。
Objective To provide the scaffold material of decellularized homograft bioprosthetic valve (HBV)for establishing of tissue engineering cardiac valve in vitro, and related technique.
制备领下腺脱细胞基质支架材料的浸提液，通过急性全身毒性试验，分析脱细胞后的生物衍生支架材料对机体的毒性作用。
The extracting liquid of submandibular gland acellular matrix scaffold material was made, and its toxicity effect to the body was analyzed by acute systemic toxicity test.
应用推荐